C200 schreef op 20 september 2017 09:30:
[...]
FDA Public meeting on HAE (patient focused feedback)On September 25, 2017, FDA is conducting a public meeting on Patient-Focused Drug Development for Hereditary Angioedema. FDA is interested in obtaining patient and caregiver perspectives on the on the impact of Hereditary Angioedema on daily life and patient views on treatment approaches.